CANAURAL (5mg+5mg+2.5mg+100000IU)/g ΩΤΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ
CANAURAL (5mg+5mg+2.5mg+100000IU)/g ΩΤΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ
Authorised
- Diethanolamine fusidate
- Framycetin sulfate
- Nystatin
- Prednisolone
Product identification
Medicine name:
CANAURAL (5mg+5mg+2.5mg+100000IU)/g ΩΤΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ
Active substance:
- Diethanolamine fusidate
- Framycetin sulfate
- Nystatin
- Prednisolone
Target species:
-
Cat
-
Dog
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Diethanolamine fusidate5.00milligram(s)1.00gram(s)
-
Framycetin sulfate5.00milligram(s)1.00gram(s)
-
Nystatin100000.00international unit(s)1.00gram(s)
-
Prednisolone2.50milligram(s)1.00gram(s)
Pharmaceutical form:
-
Ear drops, suspension
Withdrawal period by route of administration:
-
Auricular use
- Cat
-
Not applicableno withdrawal period
-
- Dog
-
Not applicableno withdrawal period
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02CA01
Legal status of supply:
-
Medicinal product subject to medical prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Dechra Veterinary Products A/S
Marketing authorisation date:
Manufacturing sites for batch release:
- Genera Istrazivanja d.o.o.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 53788/08-08-2007/K-0170201
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?: